Experience in treating molluscum contagiosum in children with imiquimod 5% cream

British Journal of Dermatology, Supplement

Volumn 149, Issue 66, 2003, Pages 25-28

  Bayerl, C ^a   Feller, G ^a   Goerdt, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Children; Imiquimod; Mollusca contagiosa; Poxvirus; Therapy response

Indexed keywords

ALPHA INTERFERON; CYTOKINE; IMIQUIMOD;

BURNING SENSATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; MOLLUSCUM CONTAGIOSUM; PAIN; PRIORITY JOURNAL; PRURITUS; REMISSION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0347320539     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0366-077x.2003.05631.x     Document Type: Conference Paper

References (26)

1. Hengge UR, Esser S, Schultewolter T et al. Self-administered topical imiquimod for the treatment of common warts and mollusca contagiosa. Br J Dermatol 2000; 143: 1026-31.
2. Liota E, Smith KJ, Buckley R, Menon P. Skelton H. Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 2000; 4: 76-82.
3. Dahl MV. Imiquimod: An immune response modifier. J Am Acad Dermatol 2000; 43: 1-5.
4. Tyring S. Imiquimod applied topically: a novel immune response modifier. Skin Ther Lett 2001; 6: 1-4.
5. Imbertson LM, Beaurline JM, Couture AM, Gibson SJ, Smith RMA, Miller RL. Cytokine induction in hairless mouse and rat after topical application of the immune response modifier, imiquimod. J Invest Dermatol 1998; 110: 734-9.
6. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000; 43: 6-11.
7. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002; 51(RR 6): 1-78.
8. Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol 2000; 43: 12-17.
9. Smith KJ, Liota E, Yeager J, Menon P. Treatment of molluscum contagiosum with topical imiquimod. Presented at the Annual Meeting of the American Academy of Dermatology, New Orleans, LA. March 19-24, 1999: abstract 352.
10. Hammes S, Greve B. Raulin C. Mollusca contagiosa. Hautarzt 2001: 52: 38-42.
11. Zabawski EJ Jr, Cockerell CJ. Topical cidofovir for molluscum contagiosum in children. Pediatr Dermatol 1999; 16: 414-15.
12. Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 1997; 133: 987-90.
13. Bettloch I, Pinazo I, Mestre F, Altes J, Villalonga C. Molluscum contagiosum in human immunodeficiency virus infection: response to zidovudine. Int J Dermatol 1989; 28: 351-2.
14. Epstein E. Cantharidin therapy for molluscum contagiosum in children. J Am Acad Dermatol 2001; 45: 638.
15. Funt TR, Mehr KA, Cantharidin: a valuable office treatment of molluscum contagiosum. South Meet J 1979; 72: 1019.
16. Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology 1994; 189: 65-8.
17. Romiti R, Ribeiro AP, Romiti N. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol 2000; 17: 495.
18. Ormerod AD, White MI, Shah SA, Benjamin N. Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br J Dermatol 1999; 141: 1051-3.
19. Niizeki K, Hashimoto K. Treatment of mollusca contagiosum with silver nitrate paste. Pediatric Dermatol 1999; 16: 359-97.
20. Oster-Schmidt C. Imiquimod: a new possibility for treatment-resistant verrucae planae. Arch Dermatol 2001; 137: 666-7.
21. Marks R, Gebauer K, Shumack S, Amies M, Bryden J. Fox TL. Owens ML. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-13.
22. Stockfleth E, Meyer T, Benninghoff B. Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001; 144: 1050-3.
23. Diaz Arrastia C, Arany I, Robazeti SC et al. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res 2001; 7: 3031-3.
24. Ahmed I, Berth-Jones J. Imiquimod. A novel treatment for lentigo maligna. Br J Dermatol 2000; 143: 843-5.
25. Mackenzie-Wood A, de Kossard S, Launey J, Wilkinson B, Owens ML. Imiquimod 5% in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-70.
26. Arevalo I, Ward B, Miller R et al. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 2001; 33: 1847-51.